This is a StreetInsider.com Premium Only Page

Concert Pharma (CNCE) – Analyst EPS View

Nov 1, 2018 11:23 AM Concert Pharmaceuticals (CNCE) PT Lowered to $26 at Mizuho Securities

Apr 5, 2017 10:54 AM Stifel Reiterates Buy Rating and $31 PT on Concert Pharma (CNCE) Following News of Minor CTP-543 Ph2 Trial Delay

May 6, 2016 09:02 AM

Sep 2, 2014 10:15 AM

Aug 12, 2014 03:23 PM

Mar 10, 2014 07:47 AM